Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2021

View Archived Issues

Targeting the NOX1-IL-6-secretory phenotype proinflammatory signaling axis can ease cell senescence

Engineered Salmonella for intracellular delivery of protein drugs to solid tumors

Researchers recapitulate anti-NMDA receptor encephalitis in zebrafish

FD-223, a novel PI3Kdelta inhibitor with potent activity in models of AML

Ndufv2 as a sex-specific genetic factor influencing mitochondrial functions

Almirall patents new TYK2 inhibitors

GWAS meta-analysis identifies genetic variants linked to vertigo

Mitobridge discloses new CD38 inhibitors

Disarm Therapeutics discloses SARM1 inhibitors

Cocrystal Pharma presents new antiviral compounds

iTeos Belgium describes new ENT1 inhibitors

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Imugene and Eureka collaborate to evaluate oncolytic virus and T-cell therapy for solid tumors

APTA-1 shows promise in coronavirus-induced acute lung injury model

Mosaic ImmunoEngineering presents structural details on cowpea mosaic virus

Studies link GRP78 to severe COVID-19 in older and obese diabetic patients

High blood LPE(20:4) levels tied to migraine

Moderna and Metagenomi collaborate to advance in vivo gene editing therapeutics

Studies show that psoriasis is more than skin-deep

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...